Clinical Trial Update: Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase II trial update for Ivonescimab in previously treated patients with advanced clear cell renal cell carcinoma, and the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ivonescimab, Clear Cell Renal Carcinoma | Phase 2 | Status: RECRUITING